Late-breaking abstract: Intracellular mechanisms behind the effect of C-reactive protein on proximal vascular cells of CTEPH patients

M. Wynants, R. Quarck, B. Meyns, M. Delcroix (Leuven, Belgium)

Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Session: Pathobiology of experimental pulmonary hypertension
Session type: Oral Presentation
Number: 3430
Disease area: Pulmonary vascular diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wynants, R. Quarck, B. Meyns, M. Delcroix (Leuven, Belgium). Late-breaking abstract: Intracellular mechanisms behind the effect of C-reactive protein on proximal vascular cells of CTEPH patients. Eur Respir J 2011; 38: Suppl. 55, 3430

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension},
Source: Eur Respir J 2012; 40: 886-894
Year: 2012



The systemic face of airway diseases: the role of C-reactive protein
Source: Eur Respir J 2006; 27: 877-879
Year: 2006


Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008


Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012


Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity.
Source: International Congress 2017 – COPD biomarkers
Year: 2017


C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006

C-reactive protein in pulmonary tuberculosis-correlation with extent and severity of the disease
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Source: Eur Respir J 2006; 27: 902-907
Year: 2006



The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019


Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Source: Eur Respir J 2008; 32: 1451-1457
Year: 2008



The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010

Independent contribution of C-reactive protein and oxygen status of arterial blood to tissue hypoxia in stable COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 771s
Year: 2007

Principles of optimization of anti-inflammatory therapy in COPD patients (pts) due to C-reactive protein (CRP) level
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021

Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010


Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction?
Source: Eur Respir J 2003; 22: Suppl. 45, 584s
Year: 2003

C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012


High-sensitive C-reactive protein is associated with reduced lung function in young adults
Source: Eur Respir J 2009; 33: 382-388
Year: 2009